UPDATE : Friday, February 22, 2019
상단여백
Celltrion Healthcare posts ₩713.5 billion in 2018 sales by Lee Han-soo 2019-02-22 17:29
Alteogen applies for P1 trial for Eylea biosimilar by Lee Han-soo 2019-02-22 16:03
Regulator OKs Bukwang’s anticancer treatment by Lee Han-soo 2019-02-22 15:29
CHA Medical Center, CG Bio to develop 3D bio-printing-based stem cell transporter by Lee Han-soo 2019-02-22 14:10
Hugel hits record-high quarterly sales by Lee Han-soo 2019-02-22 13:30
라인
Huons posts record-high sales in 2018 by Lee Han-soo 2019-02-21 17:17
Severance Hospital transfers colorectal cancer treatment candidate to Israeli firm by Lee Han-soo 2019-02-21 15:30
International groups praise Korea’s dementia-combating efforts by Lee Han-soo 2019-02-21 15:28
Mediforum verifies safety, efficacy of dementia treatment candidate by Lee Han-soo 2019-02-21 15:13
SCM, Allele to develop diabetes treatment by Lee Han-soo 2019-02-21 14:57
라인
State research organ finds new genes expediting gastritis, gastric cancer by Lee Han-soo 2019-02-21 11:26
Ewha Medical Center, LG U+ open Korea’s 1st ‘smart sleeping room’ by Lee Han-soo 2019-02-20 17:27
Pfizer’s patent barrier foils Korea’s 1st pneumococcal conjugate vaccine by Lee Han-soo 2019-02-20 16:18
‘Menopausal hormone therapy can reduce mortality’ by Lee Han-soo 2019-02-20 16:18
FDA rejects Medytox’s ‘citizen petition’ against Daewoong by Lee Han-soo 2019-02-20 14:37
라인
Court suspends FSC’s disciplinary action against Samsung BioLogics by Lee Han-soo 2019-02-20 12:12
Chong Kun Dang unveils trial results for erectile dysfunction treatment by Lee Han-soo 2019-02-19 17:36
Yuhan’s sales reached ₩1.5 trillion in 2018 by Lee Han-soo 2019-02-19 16:06
KIMES 2019 to open in Seoul by Lee Han-soo 2019-02-19 14:45
Korea spreads health insurance system to Asia by Lee Han-soo 2019-02-19 12:37
여백
여백
여백
Back to Top